An explanatory model of quality of life in schizophrenia: The role of processing speed and negative symptoms

Actas Espanolas de Psiquiatria

Volumn 40, Issue 1, 2012, Pages 10-18

  Ojeda, Natalia ^a,e   Sánchez, Pedro ^b   Peña, Javier ^a   Elizagárate, Edorta ^b,c,e   Yoller, Ana B ^b   Gutiérrez Fraile, Miguel ^c,e   Ezcurra, Jesús ^b   Napal, Olatz ^d  

^a UNIVERSITY OF DEUSTO   (Spain)

^b Hospital Psiquiatrico de Alava   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d Hospital Santiago   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Confirmatory factor analysis; Neurocognition; Processing speed; Quality of life; Schizophrenia; Symptomatology

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MALE; QUALITY OF LIFE; SCHIZOPHRENIA;

ADULT; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 84859564888     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Saleem P, Olié JP, Loo H. Social functioning and quality of life in the schizophrenic patient: Advantages of amisulpride. Int Clin Psychopharmacol. 2002; 17(1): 1-8. (Pubitemid 34056519)
2. Alptekin K, Akvardar Y, Kivircik Akdede BB, Dumlu K, lsik D, Pirincci F, et al. Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb; 29(2): 239-44. (Pubitemid 40202909)
3. Sweers K, De Schepper E, De Hert M. La capacidad de marcha está asociada a la calidad de vida (relacionada con la salud) y nivel de actividad física en pacientes con esquizofrenia: estudio preliminar. Actas Esp Psiquiatr. 2011; 39(4): 211-6.
4. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996; 153(3): 321-30. (Pubitemid 26074706)
5. Dickerson FB, Ringel NB, Parente F. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand. 1998 Aug; 98(2): 124-7. (Pubitemid 28358042)
6. Jones PB, Bebbington P, Foerster A, Lewis SW. Premorbid social underachievement in schizophrenia: Results from the Camberwell Collaborative Psychosis Study. British Journal of Psychiatry. 1993; 162(1): 65-71. (Pubitemid 23017016)
7. Heslegrave RJ, Awad AG, Voruganti LN. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci. 1997 Jul; 22(4): 235-43. (Pubitemid 127488587)
8. Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust NZJ Psychiatry. 2005 Jun;39(6): 487-92. (Pubitemid 40940993)
9. Tomida K, Takahashi N, Saito S, Maeno N, Iwamoto K, Yoshida K, et al. Relationship of psychopathological symptoms and cognitive function to subjective quality of life in patients with chronic schizophrenia. Psychiatry Clin Neurosci. 2010 02; 64(1): 62-9.
10. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up study. Schizophr Res. 2000 07; 44(1): 47-56.
11. Bow-Thomas CC, Velligan DI, Miller AL, Olsen J. Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatry Res. 1999 May 31; 86(2): 131-42. (Pubitemid 29277101)
12. Hansson L Middelboe T, Merinder L Bjarnason O, Bengtsson-Tops A, Nilsson L, et al. Predictors of subjective quality of life in schizophrenic patients living in the community. A Nordic multicentre study. Int J Soc Psychiatry. 1999 Winter; 45(4): 247-58.
13. Sota TL Heinrichs RW. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry. 2004 Sep-Oct; 45(5): 415-21. (Pubitemid 39140896)
14. Wittorf A, Wiedemann G, Buchkremer G, Klingberg S. Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. Eur Arch Psychiatry Clin Neurosci. 2008 02; 258(1): 48-58.
15. Eack SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: A meta-analysis. Schizophr Bull. 2007 09; 33(5): 1225-37.
16. Segarra Echebarria R, Ojeda dP, Zabala Rabadán A, Garcia Ormaza J, Peña Lasa J, Eguíluz Uruchurtu I, et al. Insight in first episode psychosis. Conceptual and clinical considerations. The European Journal of Psychiatry. 2010 04; 24(2): 78-86.
17. Nakamae T, Kitabayashi Y, Okamura A, Shibata K, Iwahashi S, Naka F, et al. Insight and quality of life in long-term hospitalized Japanese patients with chronic schizophrenia. Psychiatry Clin Neurosci. 2010 Aug; 64(4): 372-6.
18. Rocca P, Castagna F, Mongini T, Montemagni C, Bogetto F. Relative contributions of psychotic symptoms and insight to quality of life in stable schizophrenia. Psychiatry Res. 2010 15; 177(1-2): 71-6.
19. Nuss P, Tessier C. Antipsychotic medication, functional outcome and quality of life in schizophrenia: Focus on amisulpride. Curr Med Res Opin. 2010; 26(4): 787-801.
20. Puschner B, Angermeyer MC, Leese M, Thornicroft G, Schene A, Kikkert M, et al. Course of adherence to medication and quality of life in people with schizophrenia. Psychiatry Res. 2009 Feb 28; 165(3): 224-33.
21. Priebe S, Reininghaus U, McCabe R, Burns T, Eklund M, Hansson L et al. Factors influencing subjective quality of life in patients with schizophrenia and other mental disorders: A pooled analysis. Schizophr Res. 2010 08; 121(1-3): 251-8.
22. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology 1998 07; 12(3): 426-45.
23. Ojeda N, Sanchez P, Pena J, Elizagarate E, Yoller AB, Larumbe J, et al. Verbal fluency in schizophrenia: does cognitive performance reflect the same underlying mechanisms in patients and healthy controls? J Nerv Ment Dis. 2010 Apr; 198(4): 286-91.
24. Peña J, Ojeda N, Segarra R, Eguiluz JI, Garcia J, Gutiérrez M. Executive functioning correctly classified diagnoses in patients with first-episode psychosis: Evidence from a 2-year longitudinal study. Schizophr Res. 2011 03; 126(1-3): 77-80.
25. Simões do Couto F, Queiroz C, Barbosa T, Ferreira L, Firmino H, Viseu M, et al. Caracterización clínica y terapéutica de un muestreo portugués de pacientes con esquizofrenia. Actas Esp Psiquiatr. 2011; 39(3): 147-54.
26. SánchezP, OjedaN, ElizagárateE, PeñaJ, Ballesteros J, Yoller AB, et al. Déficit atencionales y respuesta al tratamiento farmacológico en pacientes con esquizofrenia resistente al tratamiento: Resultados mediante análisis factorial confirmatorio. Revista de Psiquiatría y Salud Mental. 2010 6; 3(2): 40-9.
27. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L Bates JA, et al. Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates. Am J Psychiatry. 2000; 157(4): 549-59. (Pubitemid 30191193)
28. Tolman AW, Kurtz MM. Neurocognitive Predictors of Objective and Subjective Quality of Life in Individuals With Schizophrenia: A Meta-Analytic Investigation. Schizophr Bull. 2010 Jul 11.
29. Aksaray G, Oflu S, Kaptanoglu C, Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct; 26(6): 1217-9. (Pubitemid 35256120)
30. Matsui M, Sumiyoshi T, Arai H, Higuchi Y, Kurachi M. Cognitive functioning related to quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan; 32(1): 280-7.
31. Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, et al. Patient outcomes in schizophrenia II: The impact of cognition. European Psychiatry. 2005 08; 20(5-6): 395-402.
32. Sánchez P, Ojeda N, Peña J, Elizagárate E, Yoller AB, Gutiérrez M, et al. Predictors of longitudinal changes in schizophrenia: The role of processing speed. J Clin Psychiatry. 2009; 70(6): 888-96.
33. Ojeda N, Peña J, Sánchez P, Elizagarate E, Ezcurra J. Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia. Schizophr Res. 2008 04; 101(1): 225-33.
34. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007; 64(5): 532-42. (Pubitemid 46718286)
35. Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry. 2002;159(8): 1395-402. (Pubitemid 34832723)
36. Rodriguez-Sanchez JM, Crespo-Facorro B, Gonzalez-Blanch C, Perez-Iglesias R, Vazquez-Barquero JL, PAFIP Group Study. Cognitive dysfunction in first-episode psychosis: the processing speed hypothesis. Br J Psychiatry Suppl 2007 Dec; 51: s107-10. (Pubitemid 350273198)
37. Ritsner MS. Predicting quality of life impairment in chronic schizophrenia from cognitive variables. Qual Life Res. 2007 Aug; 16(6): 929-37. (Pubitemid 47174885)
38. Ritsner MS, Blumenkrantz H. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits. Psychiatry Res. 2007; 149(1): 59-69. (Pubitemid 46108091)
39. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004 12; 72(1): 29-39.
40. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th, text revision ed. Washington, DC: American Psychiatric Association; 2000.
41. Kay SR, Flszbein A, Opfer LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987; 13(2): 261-76. (Pubitemid 18039085)
42. Peralta Martin V, Cuesta Zorita MJ. Validación de la escala de los síndromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994 07; 22(4): 171-7.
43. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990 07; 3(4): 247-51.
44. David AS. Insight and psychosis. British Journal of Psychiatry. 1990 06; 156: 798-808.
45. Colom F, Vieta E, Martinez-Arán A, García-García M, Reinares M, Torrent C, et al. Versión española de una escala de evaluación de la manía. Validez y fiabilidad de la escala Young. Medicina Clinica. 2002; 119: 366-71. (Pubitemid 35238074)
46. Guy W. CGI: Clinical Global Impressions. Manual for the ECDEU Assessment Battery. Chevy Chase: National Institute of Mental Health; 1970.
47. Schretlen DJ. Brief test of attention. Odessa, FL: Psychological Assessment Resources; 1996.
48. Wechsler D. The Wechsler Memory Scale-Revised. New York: Psychological Corporation; 1987.
49. Heaton RK, Chelune GJ, Talley JL Talley JL Kay GG, Curtiss G. Wisconsin card sorting test. Revised and expanded. Odessa, FL: Psychological Assessment Resources; 1993.
50. Wechsler D. WAIS-III Manual: Wechsler Adult Intelligence ScaleIII. New York: Psychological Corporation; 1997.
51. Peña-Casanova J. Programa integrado de exploración neuropsicológica. Manual. Barcelona: Masson; 1990.
52. Golden CJ. Stroop color and word test: A manual for clinical and experimental uses. Chicago: Stoelting Co; 1978.
53. Reitan R, Wolfson D. The Haldstead-Reitan Neuropsychological Test Battery. Tucson: Neuropsychology Press; 1985.
54. Heinrichs DW, Hanlon TE, Carpenter WT, Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984; 10(3): 388-98.
55. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry. 1998 Sep; 155(9): 1196-201. (Pubitemid 28402512)
56. Savilla K, Kettler L, Galletly C. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Aust N Z J Psychiatry. 2008 Jun; 42(6): 496-504. (Pubitemid 351891128)
57. Ojeda N, Sánchez P, Elizagaposarate E, Yoller AB, Ezcurra J, Ramírez I, et al. Course of cognitive symptoms in schizophrenia: a review of the literature. Actas Esp Psiquiatr. 2007; 35(4): 263-70.
58. Haro JM, Ciudad A, Alonso J, Bousoño M, Suárez D, Novick D, et al. Remisión y recaída en el tratamiento ambulatorio de los pacientes con esquizofrenia. Resultados a 3 años. Actas Esp Psiquiatr. 2008; 36(4): 187-96.
59. Herman M. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients. Int J Ment Health Nurs. 2004 Dec; 13(4): 282-91. (Pubitemid 40993929)
60. Voruganti LP, Awad AG, Parker G, Forrest C, Usmani Y, Fernando ML et al. Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine. Schizophr Res. 2007 Nov; 96(1-3): 146-55. (Pubitemid 47494646)
61. McGurk SR, Twamley EW, Sitzer Dl, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007 Dec; 164(12): 1791-802. (Pubitemid 351739231)
62. Szöke A, Trandafir A, Dupont M, Méary A, Schürhoff F, Leboyer M. Longitudinal studies of cognition in schizophrenia: Meta-analysis. British Journal of Psychiatry. 2008;192(4): 248-57. (Pubitemid 351692396)